Preliminary Examination of a Mobile Behavior Change Program for Weight Loss in Breast Cancer Survivors
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Noom Inc.
- Enrollment
- 30
- Locations
- 1
- Primary Endpoint
- Program satisfaction
Study Overview
Brief Summary
The purpose of this study is to evaluate the preliminary efficacy of a Noom Breast Cancer Weight Loss Program on weight loss outcomes, quality of life, and physical activity. Also, to qualitatively determine acceptability of this novel program among breast cancer survivors with overweight or obesity.
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Intervention Model
- Single Group
- Primary Purpose
- Health Services Research
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- Female
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •Able to understand and provide informed consent
- •18 years and older
- •Overweight or obesity (BMI ≥ 27.5)
- •Not 6 months postpartum
- •Not planning to become pregnant in the next 7 months
- •Have a smartphone that is compatible with Noom's mobile app
- •Breast cancer survivor with stage I, II, or III
- •Completed active treatment (e.g, surgery, chemo, radiation, etc.) > 6 months ago
Exclusion Criteria
- •Inability or unwillingness of a participant to give written informed consent
- •Currently pregnant or < 6 months postpartum
- •Plans to become pregnant within the next 7 months
- •Stage IV, metastatic cancer or DCIS
- •Currently taking insulin
- •Uncontrolled hypertension
Outcomes
Primary Outcomes
Program satisfaction
Time Frame: week 1 - 26 week
Satisfaction assessed via an in-house survey
Program engagement
Time Frame: weeks 1-26
Engagement with the Noom program; measured as 1. Number of App opens 2. Messages to coach 3. Number of Steps 4. Logged food 5. Logged exercise 6. Group messages and likes 7. Articles read
Weight
Time Frame: baseline to 6 months
Self-reported weight
Program retention
Time Frame: weeks 1-26
i.e. % = (total participants - number of drop out) / Total number of participants) \* 100%
Secondary Outcomes
No secondary outcomes reported